YOLFTbeta
68

Cabio Biotech Wuhan Co Ltd

688089 · SHG · Healthcare / Biotechnology

7.75CNY-0.11 (-1.40%)

Price History

Full chart

Market Stats

Previous Close7.86
Open7.86
Day Range7.73 – 8.05
52-Week Range6.91 – 26.60
Volume876.42K
Market Cap1.40B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.38
Dividend Yield0.00%
Beta0.41
50-Day Avg8.24
200-Day Avg14.81

About

Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of functional ingredients and bio-based products in China and internationally. The company offers polyunsaturated fatty acids, including arachidonic acid (ARA) and docosahexaenoic acid (DHA); terpenoids, such as beta (ß)-carotene and astaxanthin; and carbohydrates, such as N-acetylneuraminic acid and human milk oligosaccharides. Its products are used in human nutrition, including early life nutrition and dietary supplements; animal nutrition, such as economic animal and pet nutrition; personal care and cosmetics; and synthetic biology applications. The company also engages in the production of food additives and other food products; consulting services in bioengineering, environmental protection, healthcare, and food technologies; research, development, and sale of biological feed and feed additives; food wholesale; technology development; and venture capital activities. Cabio Biotech (Wuhan) Co., Ltd. was founded in 1999 and is based in Wuhan, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Dewei Yi
  • Employees500
  • HeadquartersNo. 89, Gaokeyuan Third Road, Wuhan, China, 430075, China
  • Websitehttps://www.cabio.cn

Leadership

  • Mr. Dewei YiChairman & GM · b. 1965
  • Mr. Huabiao WangCFO & Director · b. 1965
  • Mr. Huarong YiEmployee Director, Deputy GM & Secretary of the Board of Directors · b. 1976
  • Mr. Anfeng GengDeputy General Manager · b. 1976
  • Mr. Xiangyu LiDeputy General Manager · b. 1978

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue200.06M186.53M181.16M189.80M228.56M286.11M311.55M323.46M351.11M433.42M443.80M555.59M574.88M
Growth (%)--6.76%-2.88%+4.77%+20.42%+25.18%+8.89%+3.82%+8.55%+23.44%+2.39%+25.19%+3.47%
Cost of Revenue99.83M99.79M97.19M109.69M127.17M147.27M146.74M153.14M172.33M257.14M264.51M326.81M294.54M
Gross Profit100.22M86.74M83.97M80.12M101.39M138.83M164.81M170.32M178.78M176.29M179.29M228.78M574.88M
Gross Margin50.10%46.50%46.35%42.21%44.36%48.53%52.90%52.66%50.92%40.67%40.40%41.18%100.00%
Operating Expense48.42M41.12M67.00M46.75M50.39M57.81M66.03M46.12M61.62M125.20M97.68M102.30M409.91M
Operating Income51.80M45.62M16.97M33.37M51.00M81.03M98.78M124.20M117.16M51.09M81.61M126.48M164.97M
Operating Margin25.89%24.46%9.37%17.58%22.31%28.32%31.71%38.40%33.37%11.79%18.39%22.77%28.70%
EBITDA84.94M73.92M55.03M82.34M104.28M141.71M168.74M183.80M175.73M104.55M147.82M194.64M233.21M
EBITDA Margin42.46%39.63%30.38%43.38%45.62%49.53%54.16%56.82%50.05%24.12%33.31%35.03%40.57%
Net Income46.70M37.66M19.55M46.96M65.78M96.99M118.17M130.59M128.58M64.37M91.37M124.21M156.70M
Net Income Margin23.34%20.19%10.79%24.74%28.78%33.90%37.93%40.37%36.62%14.85%20.59%22.36%27.26%
R&D15.37M19.42M16.17M14.27M13.63M16.38M18.72M20.38M30.95M32.30M38.60M47.91M47.39M
R&D as % of Total Revenue7.68%10.41%8.93%7.52%5.96%5.72%6.01%6.30%8.81%7.45%8.70%8.62%8.24%
Interest Expense-838.92K2.56M298.60K77.95K77.98K85.29K54.44K435.19K1.41M765.04K567.66K1.73M
Interest Expense % of Total Revenue-0.45%1.42%0.16%0.03%0.03%0.03%0.02%0.12%0.32%0.17%0.10%0.30%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets467.92M507.41M440.43M476.78M506.37M581.19M1.30B1.38B1.45B1.61B1.61B1.69B1.86B
Total Liabilities39.68M41.52M85.60M74.17M41.98M54.99M48.26M59.30M66.68M185.77M117.60M117.27M216.16M
Total Equity428.24M465.90M354.83M403.59M465.58M526.54M1.25B1.32B1.38B1.42B1.48B1.56B1.63B
Cash61.23M97.56M16.45M44.78M75.99M122.11M844.32M847.32M664.47M494.33M239.68M153.15M278.23M
Total Debt-11.00M59.00M40.00M----2.42M33.05M11.67M18.65M-
Net Debt-61.23M-86.56M42.55M-4.78M-75.99M-122.11M-844.32M-847.32M-662.05M-461.28M-226.91M-134.50M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow39.48M46.34M44.58M62.53M100.66M106.16M131.95M145.88M103.29M176.40M68.89M173.04M270.07M
Investing Cash Flow-16.03M-20.90M-21.65M-16.20M-27.00M-25.81M-13.28M-80.48M-250.37M-338.53M-278.26M-226.03M-
Financing Cash Flow-20.11M10.89M-104.84M-20.89M-38.97M-36.10M602.84M-63.95M-39.37M-10.83M-34.02M-38.36M-
Capital Expenditure16.03M20.90M21.65M16.21M23.16M12.34M23.27M33.10M173.43M249.47M297.68M211.60M144.54M
Free Cash Flow23.45M25.44M22.93M46.33M77.50M93.82M108.67M112.78M-70.14M-73.07M-228.79M-38.55M125.53M
Dividends Paid112.00K111.83K182.95M2.39M291.41K36.00M45.00M60.00M39.60M39.60M36.07M34.02M35.87M
FCF to OCF59.40%54.89%51.43%74.08%76.99%88.38%82.36%77.31%-67.90%-41.42%-332.12%-22.28%46.48%
Dividend Paid to FCF0.48%0.44%797.88%5.15%0.38%38.37%41.41%53.20%-56.46%-54.20%-15.76%-88.23%28.57%

Earnings

Report DateDec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 30, 2021Apr 30, 2021Aug 24, 2021Oct 29, 2021Feb 28, 2022Apr 30, 2022Aug 16, 2022Oct 24, 2022Apr 27, 2023
EPS Estimate-------------
EPS Actual0.130.150.270.230.170.280.280.280.230.190.220.23-0.11
Surprise-------------
Timing----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.40B
Enterprise Value1.24B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.46
Price / Book0.92
EPS-0.38
Book Value9.11
Revenue (TTM)313.99M
Gross Profit (TTM)60.25M
EBITDA-7.52M
Profit Margin-20.64%
Operating Margin-129.10%
Return on Equity-4.47%
Return on Assets-2.62%
Shares Outstanding166.36M
Shares Float88.37M
Beta0.41
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio60.89%

Dividends

20231×
0.30Jul 18, 2023
20221×
0.24Jul 14, 2022
20211×
0.24Jul 20, 2021
20201×
0.36Jul 9, 2020

Stock Splits

  • Jul 18, 20237:5